The molecular subtypes of BC tissues (luminal A, luminal B, HER2-enriched, and TNBC) in the discovery cohort were determined by analyzing IHC staining patterns for ER, PR, HER2, and Ki-67 (Figure 3A). This evidence concerns the gene ERBB2 and breast cancer.